NICE rejects groundbreaking Alzheimer’s drugs: What it means for the UK
In a move that has triggered disappointment across the [...]
A new era in Alzheimer’s diagnosis: What the FDA’s first approved blood test means for the UK
On 16 May 2025, the U.S. Food and Drug [...]
The greatest challenges and opportunities in dementia
Dementia is one of the UK's most pressing health [...]
The greatest challenges and opportunities in dementia
Dementia is one of the UK's most pressing health [...]
The growing impact of dementia and the importance of early diagnosis
Dementia is now the leading cause of death in [...]
The growing impact of dementia and the importance of early diagnosis
Dementia is now the leading cause of death in [...]
Investing in the Dementia Age
Dementia is the UK’s number one killer and the [...]
The economic and healthcare cost of dementia
Dementia Action Week is an annual awareness raising campaign [...]
What will it take to transform Alzheimer’s with the new wave of medicines?
The first wave of effective Disease Modifying Therapies (DMT) [...]
